Description     Claims     Drawing  

EP2149372A1   [0010] 

Pathologie   [0027]  [0084] 
Cancer cell cycles. Science   [0165] 
Prognostic role of bcl-xL and p53 in childhood acute lymphoblastic leukemia (ALL)   [0177] 
Radioresistance, chemoresistance and apoptosis resistance   [0177] 
Tumorerkrankungen   [0177] 
Childhood all blasts retain phenotypic and genotypic characteristics upon long-term serial passage in NOD/SCID mice   [0177] 
Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus-infection and cancer chemotherapy by a novel flow immunocytometric method   [0177] 
Natural killer resistance of a drug-resistant leukemia cell line, mediated by up-regulation of HLA class I expression   [0177] 
In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites   [0177] 
Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications   [0177] 
Breaking chemo- and radioresistance with [213Bi]anti-CD45 antibodies in leukaemia cells   [0177] 
A critical role of glutathione in determining apoptosis sensitivity and resistance in leukaemia cells   [0177] 
Cell death in hematological tumors   [0177] 
Therapeutic opportunities for counteracting apoptosis resistance in childhood leukaemia   [0177] 
Tumor resistance to apoptosis   [0177] 
Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil   [0177] 
Molecular mechanisms and regulation of opioid receptor signaling   [0177] 
Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation   [0177] 
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry   [0177] 
Chemotherapeutic drugs sensitize pre-B ALL cells for CD95- and cytotoxic T-lymphocyte-mediated apoptosis   [0177] 
Results of a Phase I trial of sorafenib (BAY 43-9006) in combination with doxorubicin in patients with refractory solid tumors   [0177] 
Inhibitory role of cAMP on doxorubicin-induced apoptosis in pre-B ALL cells through dephosphorylation of p53 serine residues   [0177] 
Guidelines for the welfare and use of animals in cancer research   [0177]